Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study

Autor: van den Bent, Martin J ^*, Tesileanu, C Mircea S, Wick, Wolfgang, Sanson, Marc, Brandes, Alba Ariela, Clement, Paul M, Erridge, Sarah, Vogelbaum, Michael A, Nowak, Anna K, Baurain, Jean Français, Mason, Warren P, Wheeler, Helen, Chinot, Olivier L, Gill, Sanjeev, Griffin, Matthew, Rogers, Leland, Taal, Walter, Rudà, Roberta, Weller, Michael, McBain, Catherine, Reijneveld, Jaap, Enting, Roelien H, Caparrotti, Francesca, Lesimple, Thierry, Clenton, Susan, Gijtenbeek, Anja, Lim, Elizabeth, Herrlinger, Ulrich, Hau, Peter, Dhermain, Frederic, de Heer, Iris, Aldape, Kenneth, Jenkins, Robert B, Dubbink, Hendrikus Jan, Kros, Johan M, Wesseling, Pieter, Nuyens, Sarah, Golfinopoulos, Vassilis, Gorlia, Thierry, French, Pim, Baumert, Brigitta G

Publikováno v: In The Lancet Oncology June 2021 22(6):813-823

Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence

Autor: Draaisma, Kaspar, Tesileanu, C Mircea S, de Heer, Iris, Klein, Martin, Smits, Marion, Reijneveld, Jaap C, Clement, Paul M, de Vos, Filip Y F, Wick, Antje, Mulholland, Paul J, Taphoorn, Martin J B, Weller, Michael, Chinot, Olivier L, Kros, Johan M, Verschuere, Tina, Coens, Corneel, Golfinopoulos, Vassilis, Gorlia, Thierry, Idbaih, Ahmed, Robe, Pierre A, van den Bent, Martin J, French, Pim J

Publikováno v: Clinical cancer research : an official journal of the American Association for Cancer Research, 28(11), 2440-2448. American Association for Cancer Research Inc.
Clinical Cancer Research, 28(11), 2440-2448. American Association for Cancer Research Inc.
Draaisma, K, S. Tesileanu, C M, de Heer, I, Klein, M, Smits, M, Reijneveld, J C, Clement, P M, de Vos, F Y F, Wick, A, Mulholland, P J, Taphoorn, M J B, Weller, M, Chinot, O L, Kros, J M, Verschuere, T, Coens, C, Golfinopoulos, V, Gorlia, T, Idbaih, A, Robe, P A, van den Bent, M J & French, P J 2022, ' Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence : a Report from the EORTC 26091 TAVAREC Trial ', Clinical cancer research : an official journal of the American Association for Cancer Research, vol. 28, no. 11, pp. 2440-2448 . https://doi.org/10.1158/1078-0432.CCR-21-3725

Purpose: Despite recent advances in the molecular characterization of gliomas, it remains unclear which patients benefit most from which second-line treatments. The TAVAREC trial was a randomized, open-label phase II trial assessing the benefit of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4de7d68fa442c1d357276dd0505cbb8
http://www.scopus.com/inward/record.url?scp=85131225558&partnerID=8YFLogxK

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The EMA Assessment of Asciminib for the Treatment of Adult Patients With Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase Who Were Previously Treated With at Least Two Tyrosine Kinase Inhibitors.

Autor: Tesileanu, C Mircea S, Michaleas, Sotirios, Ruiz, Rocio Gonzalo, Mariz, Segundo, Fabriek, Babs O, Hennik, Paula B van, Dedorath, Jutta, Dekic, Bruna, Unkrig, Christoph, Brandt, Andreas, Koenig, Janet, Enzmann, Harald, Delgado, Julio, Pignatti, Francesco

Publikováno v: Oncologist; Jul2023, Vol. 28 Issue 7, p628-632, 5p, 1 Chart

Temozolomide and radiotherapy versus radiotherapy alone in patients with glioblastoma, IDH-wildtype: post-hoc analysis of the EORTC randomized phase 3 CATNON trial

Autor: Tesileanu, C Mircea S, Sanson, Marc, Wick, Wolfgang, Brandes, Alba A, et al, Weller, Michael

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::359c49af450b298273ad319c0d0b9046
https://doi.org/10.5167/uzh-218459